logo
  • genedrive.com
  • About us
    • Company profile
    • Board of directors
    • Advisors
  • Our product
  • News & Events
    • Press releases
    • Events
    • Media
  • Careers
    • Careers
    • Applicants Privacy Notice
  • Investor relations
    • AIM Rule 26
    • Investor relations
    • Shareholders
    • Share price information
    • Regulatory news
    • Reports & presentations
    • Analyst notes
    • Constitutional documents
    • Investor news
    • Corporate governance
    • Investor contacts
    • Company information

Investor news

Home > Investor relations > Investor news

Tuesday March 31, 2020

Genedrive CEO targets ‘fastest route to market’ for out-of-hospital coronavirus test

Monday March 30, 2020

Firms across the coronavirus treatment chain see share prices surge

Saturday March 28, 2020

Small cap movers: Genedrive skyrockets with coronavirus test production ramp-up

Wednesday March 25, 2020

Proactive news snapshot: Genedrive, Silence Therapeutics, Gfinity, SIMEC Atlantis Energy …

Wednesday March 25, 2020

Bagir shabbier as coronavirus forces factory closures

Wednesday March 25, 2020

Genedrive rockets as it says coronavirus test could be available in eight weeks

Wednesday March 18, 2020

Genedrive baby deafness test moves forward

Tuesday February 04, 2020

FTSE 100 joins global stock rally to finish firmly higher

Tuesday February 04, 2020

Genedrive frustrated by slow take-up of diagnostic kit

Monday February 03, 2020

Brace for BP as Bob Dudley steps down

Latest reports

share price graph

12 February 2020

Interim Report & Accounts 31 December 2019

View all reports >

Share price

Share price details >

  • Privacy
  • Terms of use
  • Site map

© 2017-20 genedrive plc

genedrive plcThis site uses cookies for tracking and statistical purposes. Please read our privacy policy for more information.

Don't show this againclose